ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Coherus BioSciences Announces Filing of Patent Infringement Suit Against Amgen Directed to Amgen’s Humira Biosimilar Formulation
January 28, 2019Coherus BioSciences, Inc. (Nasdaq: CHRS), a commercial biosimilar company, today announced it has filed suit against Amgen in the United States District Court (Delaware) alleging that Amgen's Humira® biosimilar, Amgevita™, infringes Coherus' U.S. patents -
Sanofi files suit in the US to defend its patent rights on Lantus
August 11, 2017Sanofi has filed a patent infringement suit to claims two patent rights on Lantus against Merck.
Pharma Sources Insight January 2025
